CA3274331A1 - Compositions pharmaceutiques de milvexian - Google Patents

Compositions pharmaceutiques de milvexian

Info

Publication number
CA3274331A1
CA3274331A1 CA3274331A CA3274331A CA3274331A1 CA 3274331 A1 CA3274331 A1 CA 3274331A1 CA 3274331 A CA3274331 A CA 3274331A CA 3274331 A CA3274331 A CA 3274331A CA 3274331 A1 CA3274331 A1 CA 3274331A1
Authority
CA
Canada
Prior art keywords
milvexian
pharmaceutical compositions
pharmaceutical
compositions
milvexian pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3274331A
Other languages
English (en)
Inventor
Sune ANDERSEN
Regina Driesen
Filip VANHOUTTE
Annelien VAN DROOGENBROECK
Bernd VAN SNICK
Elise VAES
Original Assignee
Janssen Pharmaceutica NV
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV, Bristol Myers Squibb Co filed Critical Janssen Pharmaceutica NV
Publication of CA3274331A1 publication Critical patent/CA3274331A1/fr
Pending legal-status Critical Current

Links

CA3274331A 2023-02-06 2024-02-06 Compositions pharmaceutiques de milvexian Pending CA3274331A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/483,486 2023-02-06

Publications (1)

Publication Number Publication Date
CA3274331A1 true CA3274331A1 (fr) 2024-08-15

Family

ID=

Similar Documents

Publication Publication Date Title
CA3253043A1 (fr) Compositions pharmaceutiques à base de glp1
EP4230210A4 (fr) Composition pharmaceutique stable
EP4175626A4 (fr) Nouvelles compositions pharmaceutiques
CA3261419A1 (fr) Composition pharmaceutique comprenant de la centanafadine
CA3256301A1 (fr) Compositions
IL314046A (en) RIBOCICLIB medicinal preparations
EP4370117A4 (fr) Compositions pharmaceutiques d'ozanimod
EP4171529A4 (fr) Compositions pharmaceutiques topiques
CA3304170A1 (fr) Compositions pharmaceutiques
CA3293008A1 (fr) Compositions pharmaceutiques
AU2024217663A1 (en) Milvexian pharmaceutical compositions
HK40130274A (zh) 米尔维仙药物组合物
CA3274331A1 (fr) Compositions pharmaceutiques de milvexian
HK40112458A (en) Ribociclib pharmaceutical compositions
CA3264627A1 (fr) Compositions pharmaceutiques solides d'adagrasib
AU2023901609A0 (en) Pharmaceutical composition
HK40096042A (en) Pharmaceutical compositions
HK40088134A (zh) 药物组合物
HK40090022A (en) Pharmaceutical compositions comprising bictegravir
AU2025904753A0 (en) Pharmaceutical compositions
HK40118932A (en) Pharmaceutical composition
HK40112624A (zh) 药物组合物
EP4338730A4 (fr) Composition pharmaceutique
HK40101160A (en) Pharmaceutical composition
HK40095579A (en) Pharmaceutical composition